Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
J Am Heart Assoc 2019 Oct 02
Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?
Related Questions
Which factors favor extended dual antiplatelet therapy beyond one year in ACS patients with low bleeding risk?
New answer
by at Mount Sinai Heart (May 1, 2023)
Selecting an optimal duration of dual antiplatelet therapy (DAPT) for a given patient (whether "extended" or "short" in comparison to one year) must be personalized, with a ca...
Read more (1 Answer available)
16207
×
To continue please login or register
Register
or
Sign in